nach oben

Erschienen in:

28.03.2017 | Letter to the editor

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

verfasst von: Christopher C Blyth, Gabrielle M Haeusler, Brendan J McMullan, Rishi S Kotecha, Monica A Slavin, Julia E Clark

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Morgan JE et al (2017) Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Support Care Cancer 25(1):221–228CrossRef

Brouwers MC et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):E839–E842CrossRef

Blyth, C.C., T.A. O'Brien, and P. Palasanthiran (2007) Australasian guideline for antifungal therapy in neonates and children with proven, probable and suspected fungal infecti0ons. : http://www.mycology.adelaide.edu.au/virtual/guidelines/

Blyth CC et al (2014) Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1333–1349CrossRef

Chang CC et al (2014) Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 44(12b):1389–1397CrossRef

Chau MM et al (2014) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J 44(12b):1364–1388CrossRef

Chen SC et al (2014) Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J 44(12b):1315–1332CrossRef

Cooley L et al (2014) Consensus guidelines for diagnosis, prophylaxis and management of pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 44(12b):1350–1363CrossRef

Fleming S et al (2014) Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1283–1297CrossRef

10.

Morrissey CO et al (2014) Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J 44(12b):1298–1314CrossRef

11.

Slavin MA et al (2014) Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014. Intern Med J 44(12b):1267–1276CrossRef

12.

van Hal SJ et al (2014) Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand. Intern Med J 44(12b):1277–1282CrossRef

Titel: Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
verfasst von: Christopher C Blyth
Gabrielle M Haeusler
Brendan J McMullan
Rishi S Kotecha
Monica A Slavin
Julia E Clark
Publikationsdatum: 28.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 11/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3681-0

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2017

Effectiveness of implementing a dyadic psychoeducational intervention for cancer patients and family caregivers

Dyadic interdependence of psychosocial outcomes among haematological cancer survivors and their support persons

Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy

The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis

Changes in light-, moderate-, and vigorous-intensity physical activity and changes in depressive symptoms in breast cancer survivors: a prospective observational study

A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie